Karyopharm Therapeutics Inc.

(KPTI) Trade

By |

Profile

Karyopharm Therapeutics Inc., is a clinical-stage pharmaceutical company focused on the discovery, development and subsequent commercialization of novel, first-in-class drugs directed against nuclear transport and related targets for the treatment of cancer and other major diseases. The company has discovered and is developing small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein, XPO1. Karyopharm's lead drug candidate, selinexor (KPT-330), is an orally administered agent for the treatment of cancer indications with unmet clinical need, mainly hematologic malignancies. It is also engaged in the clinical development of selinexor in various solid tumor indications.

Contact Information

Website: www.karyopharm.com
Email: ikarp@karyopharm.com
Main Phone: +1 617 658-0600
Address: 85 Wells Avenue
Address 2: 2nd Floor
State: MA
City / Town: Newton
Country: USA
Postal Code: 02459

Issuer Information

Exchange: NGS
CEO: Michael G. Kauffman
Employees: 154
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 10.01 $ -0.18 (-1.77%)
Last Price 10.01 Change $ -0.18 Change % -1.77 Tick N/A
Bid 9.90 Bid Size 1,000.00 Ask 10.29 Ask Size 200.00
Open 10.14 High 10.30 Low 9.76 Prev Close 10.19
Last Trade Volume 685,845 52 Wk Hi 21.71 52 Wk Low 9.00
Market Cap 607.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 60,707,876.00 EPS (TTM) -2.98 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 30 88
Number of Buys 16 41
Number of Sells 14 47
Net Activity -2000 -2763
Last 10 Buys Shares
Ran Frenkel 1,000
Ran Frenkel 1,000
Justin A. Renz 1,000
Barry E. Greene 1,000
Deepika R. Pakianathan 1,000
Deepika R. Pakianathan 1,000
Deepika R. Pakianathan 1,000
Deepika R. Pakianathan 1,000
Deepika R. Pakianathan 1,000
Deepika R. Pakianathan 1,000
Last 10 Sell Shares
Michael G. Kauffman 1,000
Sharon Shacham 1,000
Sharon Shacham 1,000
Michael G. Kauffman 1,000
Christopher Brett Primiano 1,000
Mansoor Raza Mirza 1,000
Michael G. Kauffman 1,000
Sharon Shacham 1,000
Sharon Shacham 1,000
Michael G. Kauffman 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 30 30 30 30
Low Target Price Estimate 14 14 14 14
Mean Target Price Estimate 22 22 22.1 22
Standard Deviation 5.16 5.16 5.11 5.16
Date of Most Recent Estimate 06/02/18 05/24/18 05/22/18 06/02/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 8 8 8
Moderate Buy 1 1 1 1
Hold 1 0 0 0
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 1.6 1.4 1.4 1.4